Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings

Clinical trial NCT01412801 · COMPLETED

Trial details

NCT number: NCT01412801
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Streptococcal Infections Gram-Positive Bacterial Infections Bacterial Infections

Start date: 2011-09-01
Primary completion: 2012-10-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.